We Help Companies Find New Sales Opportunities
Ardana has raised £11m in a share placing to fund the expansion of its Edinburgh-based pharmaceuticals business.
Ardana Bioscience is considering plans for a flotation next month to fund the expansion of its pharmaceuticals business.
Ardana, the Edinburgh-based biotechnology company, has secured £9m of new funding to expand its sales and marketing operations and to pursue further licensing opportunities.
Ardana Bioscience has acquired Europeptides, the French pharmaceuticals research company, for up to £18m, and is also in discussions with several US companies about the possibility of marketing their drugs in Europe.
Ardana, the reproductive healthcare specialist, has secured £13m of venture capital, and is now looking for up to 15 scientists and new offices on one of Edinburgh's science parks.